EP1508340A4 - INSULIN RESISTANCE ENHANCING AGENTS - Google Patents

INSULIN RESISTANCE ENHANCING AGENTS

Info

Publication number: EP1508340A4
Authority: EP; European Patent Office
Prior art keywords: insulin resistance; enhancing agents; resistance enhancing; agents; insulin
Prior art date: 2002-05-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP03730582A

Other languages

German (de)

French (fr)

Other versions

EP1508340A1 (en

Inventor

Hideaki Tojo

Tsutomu Henta

Reiko Sasada

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Takeda Pharmaceutical Co Ltd

Original Assignee

Takeda Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-24

Filing date

2003-05-22

Publication date

2009-07-01

2003-05-22 Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd

2005-02-23 Publication of EP1508340A1 publication Critical patent/EP1508340A1/en

2009-07-01 Publication of EP1508340A4 publication Critical patent/EP1508340A4/en

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Obesity (AREA)
Epidemiology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Child & Adolescent Psychology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP03730582A 2002-05-24 2003-05-22 INSULIN RESISTANCE ENHANCING AGENTS Withdrawn EP1508340A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2002151360		2002-05-24
JP2002151360		2002-05-24
PCT/JP2003/006399 WO2003099331A1 (en)	2002-05-24	2003-05-22	Insulin resistance improving agents

Publications (2)

Publication Number	Publication Date
EP1508340A1 EP1508340A1 (en)	2005-02-23
EP1508340A4 true EP1508340A4 (en)	2009-07-01

Family

ID=29561250

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP03730582A Withdrawn EP1508340A4 (en)	2002-05-24	2003-05-22	INSULIN RESISTANCE ENHANCING AGENTS

Country Status (5)

Country	Link
US (1)	US7556926B2 (en)
EP (1)	EP1508340A4 (en)
AU (1)	AU2003242396A1 (en)
CA (1)	CA2489145A1 (en)
WO (1)	WO2003099331A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2005021572A1 (en) *	2003-08-28	2005-03-10	Sankyo Company, Limited	Ptp1b antisense compound
US7483369B2 (en) *	2003-09-30	2009-01-27	Avaya Inc.	Method and apparatus for migrating to an alternate call controller
WO2005033700A1 (en) *	2003-10-03	2005-04-14	Takeda Pharmaceutical Company Limited	Method of screening insulin resistance-improving agent
US7366110B2 (en) *	2004-09-30	2008-04-29	Avaya Technology Corp.	Method and apparatus for merging call components during call reconstruction
US20060146859A1 (en) *	2005-01-04	2006-07-06	Avaya Technology Corp.	Alternate routing of media connections within a single communications system across public or private network facilities
US7457249B2 (en) *	2005-01-04	2008-11-25	Avaya, Inc.	Alternate routing of media connections within a single communications system across public or private network facilities
US7564793B2 (en) *	2005-01-04	2009-07-21	Avaya Inc.	In-band call association signaling for a single number destination
US7496056B2 (en) *	2005-01-04	2009-02-24	Avaya Inc.	Conference connections using dynamic topology switching for IP and circuit-switched fabrics
US9387183B2 (en)	2011-12-28	2016-07-12	Kuwait University	Method of treating diabetes-related impaired wound healing
MX2017001531A (en)	2014-08-08	2017-05-15	Alector Llc	Anti-trem2 antibodies and methods of use thereof.
JOP20190248A1 (en)	2017-04-21	2019-10-20	Amgen Inc	Trem2 antigen binding proteins and uses thereof
CA3067509A1 (en) *	2017-07-27	2019-01-31	Novartis Ag	Sheddase resistant trem2 variants
TWI811229B (en)	2017-08-03	2023-08-11	美商阿列克特有限責任公司	Anti-trem2 antibodies and methods of use thereof
WO2020154348A1 (en) *	2019-01-23	2020-07-30	The Regents Of The University Of California	Human genomic construct reporter cells and mouse models to screen therapeutics against microglia-expressed disease associated genes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5283173A (en) *	1990-01-24	1994-02-01	The Research Foundation Of State University Of New York	System to detect protein-protein interactions
EP0972029A1 (en)	1997-03-07	2000-01-19	Human Genome Sciences, Inc.	Human secreted proteins
US6878687B1 (en) *	1997-03-07	2005-04-12	Human Genome Sciences, Inc.	Protein HMAAD57
US6242419B1 (en)	1999-03-25	2001-06-05	Genesis Research & Development Corporation Ltd.	Compositions isolated from stromal cells and methods for their use
TW558554B (en)	1999-10-29	2003-10-21	Takeda Chemical Industries Ltd	Crystals of oxyiminoalkanoic acid derivative
JP2001340080A (en)	2000-03-31	2001-12-11	Hochi Oka	Searching system for insulin-resistant ameliorant without possibility of exacerbating diabetic retinopathy and without edema inducing action
KR20020093150A (en)	2000-05-16	2002-12-13	가부시키가이샤산와카가쿠켄큐쇼	Agents for preventing or ameliorating insulin resistance and/or obesity
CA2342376C (en) *	2001-03-20	2013-11-12	Marco Colonna	A receptor trem (triggering receptor expressed on myeloid cells) and uses thereof

2003
- 2003-05-22 WO PCT/JP2003/006399 patent/WO2003099331A1/en not_active Application Discontinuation
- 2003-05-22 US US10/515,720 patent/US7556926B2/en not_active Expired - Fee Related
- 2003-05-22 CA CA002489145A patent/CA2489145A1/en not_active Abandoned
- 2003-05-22 EP EP03730582A patent/EP1508340A4/en not_active Withdrawn
- 2003-05-22 AU AU2003242396A patent/AU2003242396A1/en not_active Abandoned

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BOUCHON AXEL ET AL: "A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells", JOURNAL OF EXPERIMENTAL MEDICINE, vol. 194, no. 8, 15 October 2001 (2001-10-15), pages 1111 - 1122, XP002528519, ISSN: 0022-1007 *

Also Published As

Publication number	Publication date
EP1508340A1 (en)	2005-02-23
US7556926B2 (en)	2009-07-07
CA2489145A1 (en)	2003-12-04
US20060014679A1 (en)	2006-01-19
AU2003242396A1 (en)	2003-12-12
WO2003099331A1 (en)	2003-12-04

Publication	Publication Date	Title
EP1508340A4 (en)	2009-07-01	INSULIN RESISTANCE ENHANCING AGENTS
UA7545S (en)	2003-07-15	LABEL "JAVA"
UA6792S (en)	2002-12-16	LABEL "MENU"
UA6029S (en)	2002-05-15	LABEL "SILVER WELL"
UA7442S (en)	2003-06-16	LABEL "ZAKROMA"
UA6892S (en)	2003-01-15	LABEL "CRIMEA"
UA6748S (en)	2002-12-16	LABEL "TEPLOLUX"
UA6581S (en)	2002-10-15	"AKVEL" LABEL
UA6256S (en)	2002-07-15	LABEL "UNIOL-2M/1"
UA7001S (en)	2003-02-17	LABEL "SLAVOLIYA"
UA6255S (en)	2002-07-15	LABEL "UNIOL-2M/2"
UA6503S (en)	2002-10-15	LABEL "DOBROSLAV"
UA6252S (en)	2002-07-15	LABEL "AZMOL KSB-1"
UA6253S (en)	2002-07-15	LABEL "AZMOL TEMP-3KN"
UA6254S (en)	2002-07-15	LABEL "AZMOL FAVORIT 2"
UA6698S (en)	2002-11-15	LABEL "SPECIAL CANDLE-CHOCOLATE"
UA6250S (en)	2002-07-15	LABEL "AZMOL SV 20/70"
UA6305S (en)	2002-08-15	LABEL "OLIA ILLICHIVSKA"
UA6012S (en)	2002-05-15	LABEL "MAXIM"
UA8632S (en)	2004-04-15	LABEL "DOVOD"
UA9246S (en)	2004-08-16	LABEL "TET-A-TET"
UA8005S (en)	2003-10-15	LABEL "BESPREDEL"
UA8343S (en)	2004-01-15	LABEL "CHIN-CHIN"
UA7825S (en)	2003-08-15	LABEL "SHORLE"
UA7181S (en)	2003-03-17	LABEL "ZYMOL-1"

Legal Events

Date	Code	Title	Description
2005-01-07	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2005-02-23	17P	Request for examination filed	Effective date: 20041124
2005-02-23	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
2005-02-23	AX	Request for extension of the european patent	Extension state: AL LT LV MK
2005-09-14	DAX	Request for extension of the european patent (deleted)
2009-07-01	A4	Supplementary search report drawn up and despatched	Effective date: 20090603
2010-05-05	17Q	First examination report despatched	Effective date: 20100408
2013-04-26	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2013-05-29	18D	Application deemed to be withdrawn	Effective date: 20121201